Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the α(v)β3 integrin to promote epidermal growth factor receptor phosphorylation and growth

Journal of Cell Biology

Volumn 139, Issue 1, 1997, Pages 279-293

  Jones, Peter Lloyd ^b   Crack, Julie ^b   Rabinovitch, Marlene ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN; MATRIX METALLOPROTEINASE INHIBITOR; TENASCIN;

ACTIN FILAMENT; ADOLESCENT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; RAT; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; CELL ADHESION; CELL DIVISION; CELL SURVIVAL; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; LIGANDS; MALE; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR AGGREGATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, VITRONECTIN; TENASCIN; TYROSINE;

EID: 0030860609     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.139.1.279     Document Type: Article

References (60)

1. Aimes, R.T., and J.P. Quigley. 1995. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating specific 3/4-and 1/4-length fragments. J. Biol. Chem. 270:5872-5876.
2. Aggeler, J., S. Frisch, and Z. Werb. 1984. Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts. J. Cell Biol. 98: 1662-1671.
3. Ailenburg, M., T. Weinstein, I. Li, and M. Silverman. 1993. Activation of pro-collagenase IV by cytochalasin D and concavalin A in cultured rat mesangial cells: linkage to cytoskeletal reorganization. J. Am. Soc. Nephrol. 4:1760-1770.
4. Bausbaum, C., and Z. Werb. 1996. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8:731-738.
5. Bendeck, M., N. Zempo, A. Clowes, R. Galardy, and M. Reidy. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75:539-545.
6. Boudreau, N., C. Sympson, Z. Werb, and M.J. Bissell. 1995a. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Wash. DC). 267:891-893.
7. Boudreau, N., C. Myers, and M.J. Bissell. 1995b. From laminin to lamin: regulation of tissue-specific gene expression by the ECM. Trends. Cell Biol. 5:1-4.
8. Boudreau, N., Z. Werb, and M.J. Bissell. 1996. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA. 93:3509-3513.
9. Brooks, P., S. Stromblad, L. Sanders, T. von Schalscha, R. Aimes, W. Stetler-Stevenson, J. Quigley, and D. Cheresh. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with αvβ3 integrin. Cell. 85:683-693.
10. Burridge K., and M. Chrzanowska-Woodnicka. 1996. Focal adhesions, contractility and signaling. In The Cytoskeleton. James Spudich, editor. Annual Reviews Inc., Palo Alto, CA. 463-519.
11. Chen, C., D. Ku, D. Kikerki, and A. Lumsden. 1996. Tenascin: a potential role in human arteriovenous PTFE graft failure. J. Surg. Res. 60:409-416.
12. Chen, C.S., M. Mrksich, S. Huang, G.M. Whitesides, and D.E. Ingber. 1997. Geometric control of cell life and death. Science (Wash. DC). 276:1425-1428.
13. Chiquet-Ehrismann, R., M Tannheimer, M. Koch, A. Brunner, J. Spring, D. Martin, S. Baumgartner, and M. Chiquet. 1994. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J. Cell Biol. 127:2093-2101.
14. Chiquet-Ehrismann, R., C. Hagios, and S. Schenk. 1995. The complexity of regulating tenascins. Bioessays. 17:873-878.
15. Chung, C., J. Murphy-Ullrich, and H. Erickson. 1996. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor annexin II. Mol. Biol. Cell. 7:883-892.
16. Chung, C.Y., and H.P. Erickson. 1994. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell Biol. 126: 539-548.
17. Davis, G.E. 1992. Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type I through RGD sites. Biochem. Biophys. Res. Commun. 182:1025-1031.
18. den Hartigh, J., P. van Bergen en Henegouwen, A. Verkleij, and J. Boonstra. 1992. The EGF receptor is an actin-binding protein. J. Cell Biol. 119:349-355.
19. Diakonova, M., B. Payrastre, A. van Velzen, W. Hage, P. van Bergen en Henegouwen, J. Boonstra, F. Cremers, and B. Humbel. 1995. Epidermal growth factor induces rapid and transient association of phospholipase C-γ1 with EGF receptor and filamentous actin at membrane ruffles of A431 cells. J. Cell Sci. 108:2499-2509.
20. End, P., G. Panayotou, A. Entwistle, M. Waterfield, and M. Chiquet. 1992. Tenascin: a modulator of growth. Eur. J. Biochem. 209:1041-1051.
21. Folkman, J., and A. Moscona. 1978. Role of cell shape in growth control. Nature (Lond.). 273:345-349.
22. Fujii, K., and S. Imamura. 1995. Cell surface proteolysis by serine proteinases enhances RGD-sensitive melanoma cell adhesion on fibrinogen and vitronectin. Exp. Cell Res. 220:201-211.
23. Galardy, R. 1993. Galardin. Drugs Future. 18:1109-1111.
24. Gronowski, A., and P. Bertics. 1995. Modulation of epidermal growth factor receptor interaction with the detergent insoluble cytoskeleton and its effects on tyrosine kinase activity. Endocrinology. 136:2198-2205.
25. Hahn, A., F. Kern, U. Jonas, M. John, F. Buhler, and T Resink. 1995. Functional aspects of vascular tenascin-C expression. J. Vasc. Res. 32:162-174.
26. Heldin, C.-H. 1995. Dimerization of cell surface receptors in signal transduction. Cell. 80:213-223.
27. Hedin, U., J. Holm, and G. Hansson. 1991. Induction of tenascin-C in rat arterial injury: relationship to altered smooth muscle cell phenotype. Am. J. Pathol. 139:649-656.
28. Hunter, T., and J. Cooper. 1985. Protein tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
29. Ingber, D. 1993. The riddle of morphogenesis: a question of solution chemistry or molecular cell engineering? Cell. 75:1249-1252.
30. Jones, P.L., C. Schmidhauser, and M.J. Bissell. 1993. Regulation of gene expression and cell function by extracellular matrix. Crit. Rev. Eukaryotic Gene Expr. 3:137-154.
31. Jones, P.L., and M. Rabinovitch. 1996. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ. Res. 79:1131-1141.
32. Jones, P.L., N. Boudreau, C. Myers, H.P. Erickson, and M.J. Bissell. 1995. Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. J. Cell Sci. 108:519-527.
33. Jones, P.L., K. Cowan, and M. Rabinovitch. 1997. Tenascin-C, proliferation and subendothelial accumulation of fibronectin in progressive pulmonary vascular disease. Am. J. Pathol. 150:1349-1360.
34. Koyama, H., E.W. Raines, K.E. Bornfeldt, J.M. Roberts, and R. Ross. 1996. Fibrillar collagen inhibits arterial smooth muscle cell proliferation through regulation of cdk2 inhibitors. Cell. 87:1069-1078.
35. Latijnhouwers, M., M. Bergers, B. van Bergen, K. Spruijt, M. Andriessen, and J. Schalkwijk. 1996. Tenascin expression during wound healing in human skin. J. Pathol. 178:30-35.
36. Lin, Y.-C., and F. Grinnell. 1993. Decreased level of PDGF-stimulated receptor autophosphorylation by fibroblasts in mechanically relaxed collagen matrices. J. Cell Biol. 122:663-672.
37. Mackie, E., T. Scott-Burden, A. Hahn, F. Kern, J. Bernhardt, J. Regenass, A. Weller, and F. Buhler. 1992. Expression of tenascin by vascular smooth muscle cells: alterations in hypertensive rats and stimulation by angiotensin II. Am. J. Pathol. 141:377-388.
38. Miyamato, S., S. Akiyama, and K. Yamada. 1995a. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science (Wash. DC). 267:883-885.
39. Miyamato, S., H. Teramoto, O. Coso, J. Gutkind, P. Burbelo, S. Akiyama, and K. Yamada. 1995b. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131:791-805.
40. Miyamato, S., H. Teramoto, J. Gutkind, and K. Yamada. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135:1633-1642.
41. Montgomery, A., R. Reisfeld, and D. Cheresh. 1994. Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. USA. 91:8856-8860.
42. Mooney, D., R. Langer, and D. Ingber. 1995. Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J. Cell Sci. 108:2311-2320.
43. Murphy-Ullrich, J., V. Lightner, I. Aukhil, Y. Yan, H. Erickson, and M. Hook. 1991. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J. Cell Biol. 115:1127-1136.
44. Nakagawa, S., P. Pawelek, and F. Grinnell. 1989. Extracellular matrix organization modulates fibroblast growth and growth factor responsiveness. Exp. Cell Res. 182:572-582.
45. Nishiyama, T., N. Akutsu, I. Horii, Y. Nakayama, T. Ozawa, and T. Hayashi. 1991. Response to growth factors of human dermal fibroblasts in a quiescent state owing to cell-matrix contact inhibition. Matrix. 11:71-75.
46. Plopper, G., H. McNamee, L. Dike, K. Bojanowski, and D. Ingber. 1995. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell 6:1349-1365
47. Prieto, A., G. Edelman, and K. Crossin. 1993. Multiple integrins mediate attachment to cytotactin/tenascin. Proc. Natl. Acad. Sci. USA. 90:10154-10158.
48. Roskelley, C., P. Desprez, and M.J. Bissell. 1994. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA. 91:12378-12382.
49. Schlessinger, J. 1988. The epidermal growth factor as a multifunctional allosteric protein. Biochemistry. 27:3119-3123.
50. Sharifi, B., D. LaFleur, C. Priola, J. Forrester, and J. Fagin. 1992. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J. Biol. Chem. 267:23910-23915.
51. Sriramarao, P., M. Mendler, and M.A. Bourdon. 1993. Endothelial cell attachment and spreading on human tenascin is mediated by α2β1 and αvβ3 integrins. J. Cell Sci. 105:1001-1012.
52. Strange, R., F. Li, S. Saurer, and R. Friis. 1992. Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development (Camb.). 115:49-58.
53. Strauss, B., R. Robinson, W. Batchelor, R. Chisholm, G. Ravi, M. Natarajan, R. Logan, S. Mehta, D. Levy, A. Ezrin, and F.W. Keeley. 1996. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ. Res. 79:541-550.
54. Sundberg, C., and K. Rubin. 1996. Stimulation of β1 integrins on fibroblasts induces PDGF-independent tyrosine phosphorytation of PDGF-β receptors. J. Cell Biol. 132:741-752.
55. Sympson, C., R. Talhouk, C. Alexander, J. Chin, S. Clift, M.J. Bissell, and Z. Werb. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125:681-693.
56. Talhouk, R., J. Chin, E. Unemori, Z. Werb, and M.J. Bissell. 1991. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development (Camb.). 112:439-449.
57. Tremble, P., R. Chiquet-Ehrismann, and Z. Werb. 1994. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol. Biol. Cell. 5:439-453.
58. Vaalamo, M., M. Weckroth, P. Puolakkainen, J. Kere, P. Saarinen, J. Lauharanta, and U. Saarialho-Kere. 1996. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br. J. Dermatol. 135:52-59.
59. Weaver, V.M., O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, C. Damsky, and M.J. Bissell. 1997. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol: 137:231-246.
60. Zempo, N., R. Kenagy, M. Bendeck, M. Clowes, and M. Reidy. 1994. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 20:209-217.